OWLIVER Trademark

Trademark Overview

On Wednesday, March 1, 2023, a trademark application was filed for OWLIVER with the United States Patent and Trademark Office. The USPTO has given the OWLIVER trademark a serial number of 97816993. The federal status of this trademark filing is SU - REGISTRATION REVIEW COMPLETE as of Friday, May 16, 2025. This trademark is owned by RUBIO METABOLOMICS, S.L.U.. The OWLIVER trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Medical health testing services for diagnostic and treatment purposes in the field of Metabolic dysfunction-Associated Steatotic Liver Disease (MASLD), Metabolic dysfunction-Associated Steatohepatitis (MASH) and at-risk Metabolic dysfunction Associated Steatohepatitis (MASH); Medical tests relating to the diagnosis and treatment of in the field of Metabolic dysfunction-Associated Steatotic Liver Disease (MASLD), Metabolic dysfunction-Associated Steatohepatitis (MASH) and at-risk Metabolic dysfunction-Associated Steatohepatitis (MASH); Medical analysis services provided by medical laboratories for diagnostic and therapeutic purposes in the field of Metabolic dysfunction-Associated Steatotic Liver Disease (MASLD), Metabolic dysfunction-Associated Steatohepatitis (MASH) and at-risk Metabolic dysfunction-Associated Steatohepatitis (MASH).
owliver

General Information

Serial Number97816993
Word MarkOWLIVER
Filing DateWednesday, March 1, 2023
Status819 - SU - REGISTRATION REVIEW COMPLETE
Status DateFriday, May 16, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 23, 2024

Trademark Statements

Pseudo MarkOW LIVER
Goods and ServicesMedical health testing services for diagnostic and treatment purposes in the field of Metabolic dysfunction-Associated Steatotic Liver Disease (MASLD), Metabolic dysfunction-Associated Steatohepatitis (MASH) and at-risk Metabolic dysfunction Associated Steatohepatitis (MASH); Medical tests relating to the diagnosis and treatment of in the field of Metabolic dysfunction-Associated Steatotic Liver Disease (MASLD), Metabolic dysfunction-Associated Steatohepatitis (MASH) and at-risk Metabolic dysfunction-Associated Steatohepatitis (MASH); Medical analysis services provided by medical laboratories for diagnostic and therapeutic purposes in the field of Metabolic dysfunction-Associated Steatotic Liver Disease (MASLD), Metabolic dysfunction-Associated Steatohepatitis (MASH) and at-risk Metabolic dysfunction-Associated Steatohepatitis (MASH).

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, February 20, 2024
Primary Code044
First Use Anywhere DateWednesday, June 1, 2011
First Use In Commerce DateSaturday, January 20, 2024

Trademark Owner History

Party NameRUBIO METABOLOMICS, S.L.U.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDerio (BIZKAIA) 48160
ES
Party NameRUBIO METABOLOMICS, S.L.U.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDerio (BIZKAIA) 48160
ES

Trademark Events

Event DateEvent Description
Wednesday, May 3, 2023TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Saturday, March 4, 2023NEW APPLICATION ENTERED
Monday, March 20, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, May 3, 2023TEAS VOLUNTARY AMENDMENT RECEIVED
Thursday, November 30, 2023ASSIGNED TO EXAMINER
Friday, December 1, 2023NON-FINAL ACTION WRITTEN
Friday, December 1, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, December 1, 2023NON-FINAL ACTION E-MAILED
Tuesday, February 20, 2024EXAMINERS AMENDMENT -WRITTEN
Tuesday, February 20, 2024EXAMINERS AMENDMENT E-MAILED
Tuesday, February 20, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, February 20, 2024EXAMINER'S AMENDMENT ENTERED
Tuesday, February 20, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 5, 2024WITHDRAWN FROM PUB - OG REVIEW QUERY
Wednesday, March 20, 2024PREVIOUS ALLOWANCE COUNT WITHDRAWN
Wednesday, March 20, 2024EXAMINERS AMENDMENT -WRITTEN
Wednesday, March 20, 2024EXAMINERS AMENDMENT E-MAILED
Wednesday, March 20, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, March 20, 2024EXAMINER'S AMENDMENT ENTERED
Wednesday, March 20, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, April 23, 2024PUBLISHED FOR OPPOSITION
Wednesday, April 3, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 18, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 23, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 12, 2024TEAS PETITION TO DIRECTOR RECEIVED
Monday, December 16, 2024SOU EXTENSION 1 FILED
Monday, December 16, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, February 18, 2025ASSIGNED TO PETITION STAFF
Wednesday, February 19, 2025PETITION TO DIRECTOR GRANTED
Monday, February 24, 2025SOU EXTENSION 1 GRANTED
Monday, February 24, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 25, 2025USE AMENDMENT FILED
Wednesday, May 14, 2025STATEMENT OF USE PROCESSING COMPLETE
Thursday, May 15, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, May 16, 2025ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, May 16, 2025NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, February 26, 2025TEAS STATEMENT OF USE RECEIVED

Related Keywords

owliver metabolic dysfunction associated steatohepatitis mash medical steatotic masld risk disease